|
C5ORF54 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.774810E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.721300E-03 |
| Normal-vs-Stage2 |
2.312300E-02 |
| Normal-vs-Stage3 |
1.953430E-01 |
| Normal-vs-Stage4 |
2.128400E-01 |
| Stage1-vs-Stage2 |
2.742200E-01 |
| Stage1-vs-Stage3 |
5.473800E-01 |
| Stage1-vs-Stage4 |
2.969000E-01 |
| Stage2-vs-Stage3 |
2.022600E-01 |
| Stage2-vs-Stage4 |
3.708800E-01 |
| Stage3-vs-Stage4 |
2.700200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.000820E-04 |
| Normal-vs-AfricanAmerican |
1.149570E-01 |
| Normal-vs-Asian |
2.051500E-02 |
| Caucasian-vs-AfricanAmerican |
1.929660E-02 |
| Caucasian-vs-Asian |
9.414800E-01 |
| AfricanAmerican-vs-Asian |
2.563600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.444200E-04 |
| Normal-vs-Female |
7.556200E-03 |
| Male-vs-Female |
3.337800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.639400E-01 |
| Normal-vs-Extreme_Weight |
3.055600E-03 |
| Normal-vs-Obese |
1.257260E-03 |
| Normal-vs-Extreme_Obese |
3.011800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.480400E-01 |
| Normal_Weight-vs-Obese |
8.335000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.369000E-01 |
| Extreme_Weight-vs-Obese |
7.719800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.805000E-01 |
| Obese-vs-Extreme_Obese |
3.448400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.192100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.961740E-04 |
| Normal-vs-Age(61-80Yrs) |
1.303630E-02 |
| Normal-vs-Age(81-100Yrs) |
3.643200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.068400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.285000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.148800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.987980E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.003220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.856400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.77873999999134E-05 |
| Normal-VS-Type2 PRCC |
1.232430E-01 |
| Normal-VS-KIRP CIMP |
6.445000E-01 |
| Normal-VS-Unclassified PRCC |
1.210380E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.380800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.810500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.950200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.099400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.732000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.228800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.272400E-02 |
| Normal-vs-N1 |
1.179760E-01 |
| Normal-vs-N2 |
9.413000E-01 |
| N0-vs-N1 |
2.735400E-01 |
| N0-vs-N2 |
4.839000E-01 |
| N1-vs-N2 |
1.748020E-01 |
|
|
